Candesartan and Spironolactone: Drug Interaction Guide

Quick answer: This combination requires caution. Candesartan and Spironolactone can be used together with adjustments and monitoring.

Interaction severity: Moderate — caution required

How Candesartan interacts with Spironolactone

ARBs reduce aldosterone-mediated potassium excretion and spironolactone blocks the aldosterone receptor, producing additive potassium retention and risk of life-threatening hyperkalemia.

What you should do

Monitor serum potassium and creatinine within 1 week of initiation, then monthly; avoid in patients with eGFR below 30 mL/min or baseline potassium above 5.0 mmol/L.

Key facts

Severity

Moderate — caution required

Mechanism

ARBs reduce aldosterone-mediated potassium excretion and spironolactone blocks the aldosterone receptor, producing addit...

Action

Monitor serum potassium and creatinine within 1 week of initiation, then monthly; avoid in patients with eGFR below 30 m...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Candesartan and Spironolactone together?

With caution. Monitor serum potassium and creatinine within 1 week of initiation, then monthly; avoid in patients with eGFR below 30 mL/min or baseline potassium above 5.0 mmol/L.

What is the severity of this interaction?

The interaction between Candesartan and Spironolactone is classified as Moderate — caution required. ARBs reduce aldosterone-mediated potassium excretion and spironolactone blocks the aldosterone receptor, producing additive potassium retention and risk of life-threatening hyperkalemia.

What should I do if I'm prescribed both?

Monitor serum potassium and creatinine within 1 week of initiation, then monthly; avoid in patients with eGFR below 30 mL/min or baseline potassium above 5.0 mmol/L. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.